Terms: = Lymphoma AND B2M, P61769, 567, ENSG00000166710 AND Treatment
75 results:
1. The prognosis of patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma: Treated with surgery or chemotherapy?
Ning Y; He H; Li Q; Zhao D; Xie D
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38400749
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
[TBL] [Abstract] [Full Text] [Related]
3. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of PD-1 monoclonal antibody plus rituximab in relapsed/refractory diffuse large B cell lymphoma patients.
Qin Y; He X; Chen X; Xie Z; Yang J; Yang S; Liu P; Zhou S; Zhang C; Gui L; Shi Y
Eur J Haematol; 2023 Sep; 111(3):356-364. PubMed ID: 37294015
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin lymphoma: A Systematic Review and Meta-analysis.
Banerjee T; Kim MS; Haslam A; Prasad V
JAMA Intern Med; 2023 May; 183(5):435-441. PubMed ID: 36939665
[TBL] [Abstract] [Full Text] [Related]
6. Primary Mediastinal B-Cell lymphoma in Children and Young Adults.
Forlenza CJ; Chadburn A; Giulino-Roth L
J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
[TBL] [Abstract] [Full Text] [Related]
7. Mortality Among Pediatric Patients With Acute Lymphoblastic Leukemia in Sweden From 1988 to 2017.
Björk-Eriksson T; Boström M; Bryngelsson IL; Lähteenmäki PM; Jarfelt M; Kalm M; Olsson DS
JAMA Netw Open; 2022 Nov; 5(11):e2243857. PubMed ID: 36441552
[TBL] [Abstract] [Full Text] [Related]
8. Risk Factors for and Outcomes of Follicular lymphoma Histological Transformation at First Progression in the GALLIUM Study.
Casulo C; Herold M; Hiddemann W; Iyengar S; Marcus RE; Seymour JF; Launonen A; Knapp A; Nielsen TG; Mir F
Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):40-48. PubMed ID: 36379880
[TBL] [Abstract] [Full Text] [Related]
9. Primary lymphoma of the uterine cervix: a clinicopathologic study of 13 cases with review of additional 54 cases in the literature.
Weng X; Huang M; Zhang M; Yang Y; Liu X; Huang Y
Virchows Arch; 2023 Feb; 482(2):419-429. PubMed ID: 36350409
[TBL] [Abstract] [Full Text] [Related]
10. Transformation of FL into DLBCL with a PMBL gene expression signature.
Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
[TBL] [Abstract] [Full Text] [Related]
11. A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Wang X; Hong Y; Meng S; Gong W; Ren T; Zhang T; Liu X; Li L; Qiu L; Qian Z; Zhou S; Zhao M; Zhai Q; Meng B; Ren X; Zhang H; Wang X
Clin Immunol; 2022 Oct; 243():109105. PubMed ID: 36055572
[TBL] [Abstract] [Full Text] [Related]
12. Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States.
Beauchemin M; Santacroce SJ; Bona K; Dang H; Alexander S; Allen K; De Los Santos C; Fisher B; Muñeton-Castaño Y; Ponce O; Vargas S; Sugalski A; Sung L; Parsons S
BMC Health Serv Res; 2022 Jun; 22(1):832. PubMed ID: 35764995
[TBL] [Abstract] [Full Text] [Related]
13. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
[TBL] [Abstract] [Full Text] [Related]
14. Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
Ernst M; Oeser A; Besiroglu B; Caro-Valenzuela J; Abd El Aziz M; Monsef I; Borchmann P; Estcourt LJ; Skoetz N; Goldkuhle M
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013365. PubMed ID: 34515338
[TBL] [Abstract] [Full Text] [Related]
15. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.
Vela V; Juskevicius D; Dirnhofer S; Menter T; Tzankov A
Virchows Arch; 2022 Feb; 480(2):403-413. PubMed ID: 34494161
[TBL] [Abstract] [Full Text] [Related]
16. c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
Bouroumeau A; Bussot L; Bonnefoix T; Fournier C; Chapusot C; Casasnovas O; Martin L; McLeer A; Col E; David-Boudet L; Lefebvre C; Algrin C; Raskovalova T; Jacob MC; Vettier C; Chevalier S; Callanan MB; Gressin R; Emadali A; Sartelet H
J Pathol Clin Res; 2021 Nov; 7(6):604-615. PubMed ID: 34374220
[TBL] [Abstract] [Full Text] [Related]
17. Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma.
McBride A; MacDonald K; Abraham I
Leuk Res; 2021 Jul; 106():106591. PubMed ID: 33957339
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib.
Balasubramanian S; Wang S; Major C; Hodkinson B; Schaffer M; Sehn LH; Johnson P; Zinzani PL; Carey J; Shreeve SM; Sun S; Gerecitano J; Vermeulen J; Staudt LM; Wilson W
Br J Haematol; 2021 Jul; 194(1):83-91. PubMed ID: 33942292
[TBL] [Abstract] [Full Text] [Related]
19. Hospitalization and mortality outcomes in the first 5 years after a childhood cancer diagnosis: a population-based study.
Steineck A; Chow EJ; Doody DR; Mueller BA
Cancer Causes Control; 2021 Jul; 32(7):739-752. PubMed ID: 33835282
[TBL] [Abstract] [Full Text] [Related]
20. Mycosis Fungoides in Children and Adolescents: A Systematic Review.
Jung JM; Lim DJ; Won CH; Chang SE; Lee MW; Lee WJ
JAMA Dermatol; 2021 Apr; 157(4):431-438. PubMed ID: 33656521
[TBL] [Abstract] [Full Text] [Related]
[Next]
